In a challenging market environment, Tilray Inc (NASDAQ:TLRY) stock has reached a 52-week low, dipping to $0.94. The cannabis company, which has been navigating through regulatory hurdles and intense ...

The U.S. cannabis market continues to be the largest in the world, but uncertainty around legalization and illicit market ...

The settlement could finally close the chapter on a five-year-old lawsuit alleging Tilray insiders secretly profited from ...

An investor class action against cannabis firm Aphria Inc., certain directors, officers and its underwriters, has been ...

TORONTO — Aphria Inc. has agreed to pay $30 million to settle a class-action lawsuit by shareholders alleging the company ...

Tilray Brands, Inc. ("Tilray" or "Company") (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the ...

Brands announced the completion of Phase I of its accelerated growth plan for its cannabis supply chain, which began with ...

NEW YORK – Tilray Brands, Inc. (NASDAQ:TLRY), a company specializing in medicinal chemicals and botanical products currently trading near its 52-week low, has reached a settlement agreement regarding ...

Tilray Brands settled a multi-year securities class action brought against its subsidiary Aphria and some of its former executives.